Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
Company: Amgen
Christopher Hale received his Ph. D. in Chemical and Biomolecular Engineering from the Johns Hopkins University, where he studied cytoskeletal mechanics using fluorescence microscopy and microrheological techniques. Christopher has been working at Amgen for 3 years. His current foci include high content screening for target discovery, image analysis, and exploration of emerging bioassay technologies.
Email Christopher Hale
Your Email:
Your Full Name:
Message :